Alternate-day prednisone therapy for pemphigus vulgaris. Preliminary report.
D015065:17-Hydroxycorticosteroids / Q000032:analysis; D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000906:Antibodies / Q000032:analysis; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D006968:Hypersensitivity, Delayed; D007111:Immunity, Cellular; D008297:Male; D008875:Middle Aged; D010392:Pemphigus / Q000188:drug therapy* / Q000276:immunology; D010913:Pituitary-Adrenal System; D011241:Prednisone / Q000008:administration & dosage* / Q000009:adverse effects; D012882:Skin Tests
D015065:17-Hydroxycorticosteroids; D000906:Antibodies; D011241:Prednisone; D006854:Hydrocortisone